Mantle Cell Lymphoma Clinical Trials in Westwood, Kansas

4 studies are recruiting for mantle cell lymphoma in Westwood, Kansas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

    This phase III trial tests whether continuous or intermittent zanubrutinib after achieving a complete remission (CR) with rituximab works in older adult patients with mantle cell lymphoma (MCL) who have not received treatment in the past (previously untreated). Rituximab is a monoclonal antibody th…

    Stage
    Phase 3
    Ages
    60 and older
    Site
    University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas
    Locations
    238 in total
    Run by
    Alliance for Clinical Trials in Oncology

    See if you can join NCT05976763 on ClinicalTrials.gov

  2. A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

    The purpose of this study is to establish the safety of novel dosing and ramp-up schedules for sonrotoclax in participants with hematological malignancies.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    The University of Kansas Cancer Center, Westwood, Kansas
    Locations
    17 in total
    Run by
    BeOne Medicines

    See if you can join NCT06697184 on ClinicalTrials.gov

  3. A Long-term Extension Study of PCI-32765 (Ibrutinib)

    The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to ibrutinib for participants who are currently enrolled in ibrutinib studies that have been completed according to the parent protocol, are actively rece…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Kansas University Medical Center, Westwood, Kansas
    Locations
    175 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT01804686 on ClinicalTrials.gov

  4. A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

    This is an open-label, multicenter, Phase 1/2 study evaluating the safety and efficacy of CTX112™ in subjects with relapsed or refractory B-cell malignancies.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of Kansas, Westwood, Kansas
    Locations
    7 in total
    Run by
    CRISPR Therapeutics AG

    See if you can join NCT05643742 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.